PNLIP and metabolic syndrome: To the best of our knowledge, this is the first time that the complexation of β-LG, in different molecular states with CA is studied, aiming to obtain functional composites with enhanced antioxidant, inhibitory effects towards enzymes associated with metabolic syndrome, including α-glucosidase and α-amylase, and pancreatic lipase.